Orexin deficiency modulates cognitive flexibility in a sex-dependent manner.

animal models of schizophrenia anxiety attentional set shifting cognitive flexibility food consumption learning and memory narcolepsy neuropeptides orexin transgenic mice

Journal

Genes, brain, and behavior
ISSN: 1601-183X
Titre abrégé: Genes Brain Behav
Pays: England
ID NLM: 101129617

Informations de publication

Date de publication:
03 2021
Historique:
received: 28 05 2020
revised: 01 10 2020
accepted: 14 10 2020
pubmed: 19 10 2020
medline: 15 2 2022
entrez: 18 10 2020
Statut: ppublish

Résumé

Cognitive flexibility is an important executive function and refers to the ability to adapt behaviors in response to changes in the environment. Of note, many brain disorders are associated with impairments in cognitive flexibility. Several classical neurotransmitter systems including dopamine, acetylcholine and noradrenaline are shown to be important for cognitive flexibility, however, there is not much known about the role of neuropeptides. The neuropeptide orexin, which is brain-widely released by neurons in the lateral hypothalamus, is a major player in maintaining sleep/wake cycle, feeding behavior, arousal, and motivational behavior. Recent studies showed a role of orexin in attention, cognition and stress-induced attenuation of cognitive flexibility by disrupting orexin signaling locally or systemically. However, it is not known so far whether brain-wide reduction or loss of orexin affects cognitive flexibility. We investigated this question by testing male and female orexin-deficient mice in the attentional set shifting task (ASST), an established paradigm of cognitive flexibility. We found that orexin deficiency impaired the intra-dimensional shift phase of the ASST selectively in female homozygous orexin-deficient mice and improved the first reversal learning phase selectively in male homozygous orexin-deficient mice. We also found that these orexin-mediated sex-based modulations of cognitive flexibility were not correlated with trait anxiety, narcoleptic episodes, and reward consumption. Our findings highlight a sexually dimorphic role of orexin in regulating cognitive flexibility and the need for further investigations of sex-specific functions of the orexin circuitry.

Identifiants

pubmed: 33070452
doi: 10.1111/gbb.12707
doi:

Substances chimiques

Hcrt protein, mouse 0
Orexins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12707

Informations de copyright

© 2020 The Authors. Genes, Brain and Behavior published by International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.

Références

Leeson VC, Robbins TW, Matheson E, et al. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol. Psychiatry. 2009;66:586-593.
Waltz JA. The neural underpinnings of cognitive flexibility and their disruption in psychotic illness. Neuroscience. 2017;345:203-217.
Floresco SB, Zhang Y, Enomoto T. Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behav. Brain Res. 2009;204:396-409.
Chudasama Y, Robbins TW. Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol. Psychol. 2006;73:19-38.
Manes F, Sahakian B, Clark L, et al. Decision-making processes following damage to the prefrontal cortex. Brain. 2002;125:624-639.
Mukhopadhyay P, Dutt A, Kumar Das S, et al. Identification of neuroanatomical substrates of set-shifting ability: evidence from patients with focal brain lesions. Prog. Brain Res. 2007;168:95-104.
Birrell JM, Brown VJ. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 2000;20:4320-4324.
Ng CW, Noblejas MI, Rodefer JS, Smith CB, Poremba A. Double dissociation of attentional resources: prefrontal versus cingulate cortices. J. Neurosci. 2007;27:12123-12131.
Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J. Neurosci. 2005;25:532-538.
Boulougouris V, Tsaltas E. Serotonergic and dopaminergic modulation of attentional processes. Prog. Brain Res. 2008;172:517-542.
Tait D, Chase E, Brown V. Attentional set-shifting in rodents: a review of behavioural methods and pharmacological results. Curr. Pharm. Des. 2014;20:5046-5059.
Prado VF, Janickova H, Al-Onaizi MA, et al. Cholinergic circuits in cognitive flexibility. Neuroscience. 2017;345:130-141.
Grospe GM, Baker PM, Ragozzino ME. Cognitive flexibility deficits following 6-OHDA lesions of the rat dorsomedial striatum. Neuroscience. 2018;374:80-90.
Papaleo F, Crawley JN, Song J, et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J. Neurosci. 2008;28:8709-8723.
Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573-585.
De Lecea L, Kilduff TS, Peyron C. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc National Academy Sci United States America. 1998;95:322-327.
Peyron C, Tighe DK, Van Den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998;18:9996-10015.
Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 1999;827:243-260.
Date Y, Ueta Y, Yamashita H, et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U. S. A. 1999;96:748-753.
Marcus JN, Aschkenasi CJ, Lee CE, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 2001;435:6-25.
Peyron C, Kilduff TS. Mapping the hypocretin/orexin neuronal system: an unexpectedly productive journey. J. Neurosci. 2017;37:2268-2272.
Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 2007;8:171-181.
Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98:437-451.
Tsujino N, Sakurai T. Role of orexin in modulating arousal feeding and motivation. Front. Behav. Neurosci. 2013;7:28
Sakurai T. The role of orexin in motivated behaviours. Nat. Rev. Neurosci. 2014;15:719-731.
Li J, Hu Z, De Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br. J. Pharmacol. 2014;171:332-350.
Khalil R, Fendt M. Increased anxiety but normal fear and safety learning in orexin-deficient mice. Behav. Brain Res. 2017;320:210-218.
Boschen KE, Fadel JR, Burk JA. Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867 disrupts attentional performance in rats. Psychopharmacology (Berl). 2009;206:205-213.
Fadel J, Burk JA. Orexin/hypocretin modulation of the basal forebrain cholinergic system: role in attention. Brain Res. 2010;1314:112-123.
Piantadosi PT, Holmes A, Roberts BM, Bailey AM. Orexin receptor activity in the basal forebrain alters performance on an olfactory discrimination task. Brain Res. 2015;1594:215-222.
Calva CB, Fadel JR. Intranasal administration of orexin peptides: mechanisms and therapeutic potential for age-related cognitive dysfunction. Brain Res. 2020;1731:145921.
Bayard S, Croisier Langenier M, Cochen De Cock V, et al. Executive control of attention in narcolepsy. PLoS One. 2012;7:e33525.
Deutch AY, Bubser M. The orexins/hypocretins and schizophrenia. Schizophr. Bull. 2007;33:1277-1283.
Fronczek R, van Geest S, Frölich M, et al. Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol. Aging. 2012;33:1642-1650.
Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med. Res. Rev. 2015;35:152-197.
Cortese S, Konofal E, Lecendreux M. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role? Med. Hypotheses. 2008;71:770-775.
Scheggia D, Mastrogiacomo R, Mereu M, et al. Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nat. Commun. 2018;9:1-11.
Haynes AC, Jackson B, Chapman H, et al. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regulatory Peptides. 2000;96:45-51.
Piccoli L, Di Bonaventura MVM, Cifani C, et al. Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology. 2012;37:1999-2011.
Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM. Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J. Neurosci. 2008;28:11124-11130.
Kos T, Nikiforuk A, Rafa D, Popik P. The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology (Berl). 2011;214:911-921.
Zajo KN, Fadel JR, Burk JA. Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons. Psychopharmacology (Berl). 2016;233:639-647.
Grafe LA, Cornfeld A, Luz S, Valentino R, Bhatnagar S. Orexins mediate sex differences in the stress response and in cognitive flexibility. Biol. Psychiatry. 2017;81:683-692.
Calva CB, Fayyaz H, Fadel JR. Effects of intranasal orexin-a (hypocretin-1) administration on neuronal activation, neurochemistry and attention in aged rats. Front. Aging Neurosci. 2020;11:362.
Brown VJ, Tait DS. Attentional set-shifting across species. Current Topics Behav Neurosci. 2016;28:363-395.
Li R, Singh M. Sex differences in cognitive impairment and Alzheimer's disease. Front. Neuroendocrinol. 2014;35:385-403.
Henderson VW, Buckwalter JG. Cognitive deficits of men and women with alzheimer's disease. Neurology. 1994;44:90-96.
Jöhren O, Neidert SJ, Kummer M, Dominiak P. Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides. 2002;23:1177-1180.
Funabashi T, Hagiwara H, Mogi K, Mitsushima D, Shinohara K, Kimura F. Sex differences in the responses of orexin neurons in the lateral hypothalamic area and feeding behavior to fasting. Neurosci. Lett. 2009;463:31-34.
Blume SR, Nam H, Luz S, Bangasser DA, Bhatnagar S. Sex- and age-dependent effects of orexin 1 receptor blockade on open-field behavior and neuronal activity. Neuroscience. 2018;381:11-21.
James MH, Campbell EJ, Walker FR, et al. Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats. Front. Behav. Neurosci. 2014;8:244.
Garner JP, Thogerson CM, Würbel H, et al. Animal neuropsychology: validation of the intra-dimensional extra-dimensional set shifting task for mice. Behav. Brain Res. 2006;173:53-61.
Janitzky K, Lippert MT, Engelhorn A, et al. Optogenetic silencing of locus coeruleus activity in mice impairs cognitive flexibility in an attentional set-shifting task. Front. Behav. Neurosci. 2015;9:286.
Broberg BV, Glenthøj BY, Dias R, Larsen DB, Olsen CK. Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia-sub-chronic and early postnatal PCP treatment in attentional set-shifting. Psychopharmacology (Berl). 2009;206:631-640.
Bissonette GB, Powell EM. Reversal learning and attentional set-shifting in mice. Neuropharmacology. 2012;62:1168-1174.
Wallace J, Marston HM, McQuade R, Gartside SE. Evidence that the attentional set shifting test in rats can be applied in repeated testing paradigms. J. Psychopharmacol. 2014;28:691-696.
Bissonette GB, Powell EM, Roesch MR. Neural structures underlying set-shifting: roles of medial prefrontal cortex and anterior cingulate cortex. Behav. Brain Res. 2013;250:91-101.
Robinson OJ, Vytal K, Cornwell BR, et al. The impact of anxiety upon cognition: perspectives from human threat of shock studies. Front. Hum. Neurosci. 2013;7:203.
Strawn JR, Pyne-Geithman GJ, Ekhator NN, et al. Low cerebrospinal fluid and plasma orexin-a (hypocretin-1) concentrations in combat-related posttraumatic stress disorder. Psychoneuroendocrinology. 2010;35:1001-1007.
Johnson PL, Truitt W, Fitz SD, et al. A key role for orexin in panic anxiety. Nat. Med. 2010;16:111-115.
Maloney EA, Sattizahn JR, Beilock SL. Anxiety and cognition. Wiley Interdiscip. Rev. Cogn. Sci. 2014;5:403-411.
Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 2000;6:991-997.
Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27:469-474.
Nishino S, Okuro M, Kotorii N, et al. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol. (Oxf). 2010;198:209-222.
Naumann A, Bellebaum C, Daum I. Cognitive deficits in narcolepsy. J. Sleep Res. 2006;15:329-338.
Baykal S, Albayrak Y, Durankuş F, et al. Decreased serum orexin a levels in drug-naive children with attention deficit and hyperactivity disorder. Neurol. Sci. 2019;40:593-602.
Auberson YP, Troxler T, Zhang X, et al. Ergoline-derived inverse agonists of the human H3 receptor for the treatment of narcolepsy. ChemMedChem. 2014;9:1683-1696.
Morawska M, Buchi M, Fendt M. Narcoleptic episodes in orexin-deficient mice are increased by both attractive and aversive odors. Behav. Brain Res. 2011;222:397-400.
Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J. Neurosci. 2012;32:12305-12311.
Clark EL, Baumann CR, Cano G, Scammell TE, Mochizuki T. Feeding-elicited cataplexy in orexin knockout mice. Neuroscience. 2009;161:970-977.
Albrecht A, Stork O. Circadian rhythms in fear conditioning: an overview of behavioral, brain system, and molecular interactions. Neural Plast. 2017;2017:1-12.
Verma P, Hellemans KGC, Choi FY, Yu W, Weinberg J. Circadian phase and sex effects on depressive/anxiety-like behaviors and HPA axis responses to acute stress. Physiol. Behav. 2010;99:276-285.
Roberston AL, Balachandran RC, Mahoney MM, et al. Circadian disruption affects initial learning but not cognitive flexibility in an automated set-shifting task in adult long-Evans rats. Physiol. Behav. 2017;179:226-234.

Auteurs

Archana Durairaja (A)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University, Magdeburg, Germany.

Markus Fendt (M)

Institute for Pharmacology and Toxicology, Otto-von-Guericke University, Magdeburg, Germany.
Center of Behavioral Brain Sciences, Otto-von-Guericke University, Magdeburg, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH